Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.10.30.684628

Nanoscale synaptic remodeling at corticostriatal circuits predicts flexible action control

Abstract

Synaptic plasticity is a fundamental substrate of behavioral adaptation, yet the underlying molecular dynamics remain poorly defined. We tested the hypothesis that, within striatal circuits, flexibility relies on nanoscale remodeling of synaptic machinery coupling anterograde glutamatergic transmission to retrograde endocannabinoid signaling, a process disrupted in states of rigidity and aging. In the dorsolateral striatum, we found cell-type-specific facilitation of metabotropic glutamate receptor 5 (mGlu5)-dependent, endocannabinoid-mediated long-term depression at cortico-striatal synapses of indirect pathway neurons in flexible goal-directed behavior, but not after training promoting inflexibility. Stochastic Optical Reconstruction Microscopy (STORM) super-resolution imaging revealed that behavioral adaptation, but not rigidity, is accompanied by increased postsynaptic abundance of mGlu5 and diacylglycerol lipase- (DAGL), an endocannabinoid-synthesizing enzyme, and presynaptic CB1 cannabinoid receptors. In parallel, the nanoscale distance between mGlu5 and DAGL is reduced in postsynaptic spine heads. These nanoscale changes emerged within the time window required for behavioral updating. Intriguingly, the molecular densities of mGlu5, DAGL, and CB1 receptors predict the strength of behavioral adaptation. In aging mice, these nanoscale changes were absent in association with behavioral rigidity. These findings identify a nanoscale synaptic remodeling mechanism that enables behavioral flexibility and reveal how its failure contributes to rigidity, including that observed in aging.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Paget-Blanc, V., Zoldi, M., Cavaccini, A., Miczan, V., Dudok, B., Katona, I., Tonini, R.. 2025-10-31. Nanoscale synaptic remodeling at corticostriatal circuits predicts flexible action control. https://doi.org/10.1101/2025.10.30.684628

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗